|

Ex vivo Expanded Human Autologous Regulatory T Cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1

Indications

  • Type 1 Diabetes Mellitus1
  • Diabetes1

Other1 trial

Immunotherapy with Autologous Tregs in T1DM
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.